Skip to main content

Advertisement

Log in

Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands

Social Psychiatry and Psychiatric Epidemiology Aims and scope Submit manuscript

Abstract

Purpose

Differences in incidence and prevalence of ADHD medication use between ethnic groups have been reported. Goal of this study was to determine whether there are also differences in usage patterns of ADHD medication among native Dutch children and adolescents and those with a Moroccan, Turkish and Surinam cultural background in the Netherlands between 1999 and 2010.

Methods

In a cohort of ADHD patients <19 years (N = 817) incident use and discontinuation of ADHD medication were measured for ethnicity and adjusted for age, gender and socio-economic status.

Results

A significant higher proportion of ADHD-diagnosed patients from Moroccan (32 %) and Turkish (42 %) cultural background never used ADHD medication compared to Dutch natives (21 %). One-fifth of native Dutch and Turkish patients already used ADHD medication before the ADHD diagnosis date. Discontinuation of ADHD medication within 5 years was significantly higher in Moroccan [HR 2.4 (95 % CI 1.8–3.1)] and Turkish [HR 1.7 (95 % CI 1.1–2.6)] patients. A sensitivity analysis with a zip code-matched comparison between Dutch natives and non-natives showed similar results, suggesting this effect is probably not explained by socio-economic status (SES).

Conclusion

Differences are found in prescribing and use of ADHD medication between patients with a different cultural background. Native Dutch and Turkish patients start more frequently with ADHD medication before the ADHD diagnose date, which can be an indication of differences in either referral patterns and/or access to care. A higher percentage of patients with a Moroccan and Turkish cultural background never start using ADHD medication at all and discontinuation rate is higher compared to Dutch natives and Surinamese.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Aacap ADHD Guideline (2007) Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46(7):894–921

    Article  Google Scholar 

  2. Nutt DJ, Fone K, Asherson P, Bramble D, Hill P, Matthews K et al (2007) British Association for Psychopharmacology. Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 21(1):10–41

    Article  CAS  PubMed  Google Scholar 

  3. Atkinson M, Hollis C (2010) NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed 95(1):24–27

    Article  CAS  PubMed  Google Scholar 

  4. Murphy K, Barkley R (1996) Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Atten Disorder 3:147–161

    Article  Google Scholar 

  5. McDonnell MA, Glod C (2003) Prevalence of psychopathology in preschool-age children. Child Adolesc Psychiatr Nurs 16(4):141–152

    Article  Google Scholar 

  6. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O et al (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163(4):716–723

    Article  PubMed Central  PubMed  Google Scholar 

  7. Ten Have M, Graaf de R, Dorsselaer S, Verdurmen J, Land van’t H, Vollenbergh W et al (2006) Prevalentie van impulsstoornissen. Resultaten van the European Study of Epidemiology of Mental Disorders (ESEMeD). Trimbos Instituut, Utrecht

  8. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007) The worldwide prevalence of ADHD: a systematic review and meta-regression analysis. Am J Psychiatry 164(6):942–948

    Article  PubMed  Google Scholar 

  9. de Ridder T, Bruffaerts R, Danckaerts M, Bonnewyn A, Demyttenaere K (2008) ADHD in de Belgische bevolking; een epidemiologische exploratieve studie. Tijdschr Psychiatr 50(8):499–508

    PubMed  Google Scholar 

  10. Michielsen M, Semeijn E, Comijs HC, van de Ven P, Beekman AT, Deeg DJ et al (2012) Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands. Br J Psychiatry 201(4):298–305

    Article  PubMed  Google Scholar 

  11. Wichstrøm L, Berg-Nielsen TS, Angold A, Egger HL, Solheim E, Sveen TH (2012) Prevalence of psychiatric disorders in preschoolers. J Child Psychol Psychiatry 53(6):695–705

    Article  PubMed  Google Scholar 

  12. Robison L, Sclar D, Traer T, Galins R (1999) National trends in prevalence of attention-deficit/hyperactivity disorder and the prescription of methylphenidate among school-age children: 1990–1995. Clin Pediatrics 38:209–217

    Article  CAS  Google Scholar 

  13. Miller A, Lalonde C, McGrail K, Armstrong R (2001) Prescription of methylphenidate to children and youth, 1990–1996. Can Med Assoc J 165:1489–1494

    CAS  Google Scholar 

  14. Schirm E, Tobi H, Zito J, de Jong-van den Berg LT (2001) Psychotropic medication in children: a study from the Netherlands. Pediatrics 108:E25–E29

    Article  CAS  PubMed  Google Scholar 

  15. Zito J, Safer D, dosReis S et al (2000) Trends in prescribing of psychotropic medications to preschoolers. JAMA 83:1025–1030

    Article  Google Scholar 

  16. Reid R, Hakendorf P, Prosser B (2002) Use of stimulant medication for ADHD in South Australia. J Am Acad Child Adolesc Psychiatry 41:906–913

    Article  PubMed  Google Scholar 

  17. Hugtenburg J, Heerdink E, Egberts A (2004) Increased psychotropic drug consumption by children in the Netherlands during 1995–2001 is caused by increased use of methylphenidate by boys. Eur J Clin Pharmacol 60:377–379

    Article  CAS  PubMed  Google Scholar 

  18. Faber A, de Jong-van den Berg LT, van den Berg PB, Tobi H (2005) Psychotropic comedication among stimulant-treated children in the Netherlands. J Child Adolesc Psychofarm 15:38–43

    Article  Google Scholar 

  19. Robison L, Sclar D, Skaer T (2005) Trends in ADHD and stimulant use among adults: 1995–2002. Psychiatr Serv 56:1497

    Article  PubMed  Google Scholar 

  20. Vinker S, Vinker R, Elhayany A (2006) Prevalance of methylphenidate use among Israeli children: 1998–2004. Clin Drug Investig 26:161–167

    Article  PubMed  Google Scholar 

  21. Castle L, Aubert R, Verbrugge R, Khalid M, Epstein R (2007) Trends in medication treatment for ADHD. J Att Disord 10:335–342

    Article  Google Scholar 

  22. Zito J, Safer D, Satish Valluri M, Gardner J, Korelitz J, Mattison D (2007) Psychotherapeutic medication prevalence in medicaid-insured preschoolers. J Child Adolesc Psychofarm 17:195–203

    Article  Google Scholar 

  23. Winterstein A, Gerhard T, Shuster J, Zito J, Johnson M (2008) Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in medicaid database. Ann Pharmacother 42:24–31

    Article  PubMed  Google Scholar 

  24. van den Ban E, Souverein P, Swaab H, van Engeland H, Heerdink R, Egberts T (2010) Incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001–2006. J Child Adolesc Psychopharmacol 20:55–61

    Article  PubMed  Google Scholar 

  25. Comer J, Olfson M, Mojtabai R (2010) National trends in child and adolescent psychotropic polypharmacy in office based practice, 1996–2007. J Am Acad Child Adolesc Psychiatry 49(10):1001–1010

    Article  PubMed Central  PubMed  Google Scholar 

  26. Hodgkins P, Sasane R, Meijer WM (2011) Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther 3:188–203

    Article  Google Scholar 

  27. Fullerton CA, Epstein AM, Frank RG, Normand SL, Fu CX, McGuire TG (2012) Medication use and spending trends among children with ADHD in Florida’s Medicaid program, 1996–2005. Psychiatr Serv 63(2):115–121

    Article  PubMed  Google Scholar 

  28. Lindemann C, Langner I, Kraut A, Banaschewski T, Schad-Hansjosten T, Petermann U et al (2012) Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. J Child Adolesc Psychopharmacol 22(4):307–314

    Article  CAS  PubMed  Google Scholar 

  29. Zuvekas S, Vitiello B (2012) Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 169(2):160–166

    Article  PubMed Central  PubMed  Google Scholar 

  30. Raghavan R, Brown DS, Thompson H, Ettner SL, Clements LM, Key W (2012) Medicaid expenditures on psychotropic medications for children in the child welfare system. J Child Adolesc Psychopharmacol 22(3):182–189

    Article  PubMed Central  PubMed  Google Scholar 

  31. Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA (1997) Methylphenidate patterns among medicaid youths. Psychopharmacol Bull 33(1):143–147

    CAS  PubMed  Google Scholar 

  32. Blanco C, Patel SR, Liu L, Jiang H, Lewis-Fernández R, Schmidt AB et al (2007) National trends in ethnic disparities in mental health care. Med Care 45(11):1012–1019

    Article  PubMed  Google Scholar 

  33. Bauermeister JJ, Canino G, Bravo M, Ramírez R, Jensen PS, Chavez L et al (2003) Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children. J Am Acad Child Adolesc Psychiatry 42(7):851–855

    Article  PubMed  Google Scholar 

  34. Bussing R, Zima BT, Mason D, Hou W, Garvan CW, Forness S (2005) Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15(1):78–87

    Article  PubMed  Google Scholar 

  35. dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL (2005) Multiple psychotropic medication use for youths: a two-state comparison. J Child Adolesc Psychopharmacol 15(1):68–77

    Article  PubMed  Google Scholar 

  36. Radigan M, Lannon P, Roohan P, Gesten F (2005) Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population. J Child Adolesc Psychopharmacol 15(1):44–56

    Article  PubMed  Google Scholar 

  37. Raghavan R, Zima BT, Andersen RM, Leibowitz AA, Schuster MA, Landsverk J (2005) Psychotropic medication use in a national probability sample of children in the child welfare system. J Child Adolesc Psychopharmacol 15(1):97–106

    Article  PubMed  Google Scholar 

  38. Stevens J, Harman JS, Kelleher KJ (2005) Race/ethnicity and insurance status as factors associated with ADHD treatment patterns. J Child Adolesc Psychopharmacol 15(1):88–96

    Article  PubMed  Google Scholar 

  39. Zito JM, Safer DJ, Zuckerman IH, Gardner JF, Soeken K (2005) Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths. Psychiatr Serv 56(2):157–163

    Article  PubMed  Google Scholar 

  40. Bruckner TA, Hodgson A, Mahoney CB, Fulton BD, Levine P, Scheffler RM (2012) Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications. Pharmacoepidemiol Drug Saf 21(4):442–449

    Article  PubMed  Google Scholar 

  41. Brown RT, Sexson SB (1988) A controlled trial of methylphenidate in black adolescents. Attentional, behavioral, and physiological effects. Clin Pediatr (Phila) 27(2):74–81

    Article  CAS  Google Scholar 

  42. Arnold LE, Elliot M, Sachs L, Bird H, Kraemer HC, Wells KC et al (2003) Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD. J Consult Clin Psychol 71(4):713–727

    Article  PubMed  Google Scholar 

  43. Bauermeister JJ, Bird HR, Shrout PE, Chavez L, Ramírez R, Canino G (2011) Short-term persistence of DSM-IV ADHD diagnoses: influence of context, age, and gender. Am Acad Child Adolesc Psychiatry 50(6):554–562

    Article  Google Scholar 

  44. Statistics Netherlands (CBS) (2005) StatLine database. http://www.cbs.nl/NR/rdonlyres/92AA630F-7BD8-4DFB-B27D-A7229D329204/0/2005eindrapportmgzpub.pdf. Accessed 16 Oct 2014

  45. Statistics Netherlands (CBS) (2005) StatLine database. http://www.cbs.nl/nl-NL/. Accessed 3 Jan 2014

  46. Zwirs BW, Burger H, Schulpen TW, Wiznitzer M, Fedder H, Buitelaar JK (2007) Prevalence of psychiatric disorders among children of different ethnic origin. J Abnorm Child Psychol 35(4):556–566

    Article  PubMed  Google Scholar 

  47. Boon E, De Haan AM, De Boer S (2010) Verschillen in etnische achtergrond van forensische en reguliere jeugd-ggz-cliënten. Kind en Adolescent 13:16–28

    Article  Google Scholar 

  48. Zwirs BW, Burger H, Buitelaar JK, Schulpen TW (2006) Ethnic differences in parental detection of externalizing disorders. Eur Child Adolesc Psychiatry 15(7):418–426

    Article  PubMed  Google Scholar 

  49. Nuijen J, Romijn G, van Mierlo F, van der Zanden A, Onrust S (2010) Psychische problematiek bij kinderen en jongeren: 135 Over ontwikkelingen in het vóórkomen, de toegang tot en het gebruik van de jeugd-GGZ Trimbos-instituut, Utrecht, Netherlands, Institute of Mental health and addiction, pp 135–175

  50. Scheppers E, van Dongen E, Dekker J, Geertzen J, Dekker J (2006) Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract 23(3):325–348

    Article  PubMed  Google Scholar 

  51. Alegria M, Lin J, Green J, Sampson N, Gruber M, Kessler M (2012) Role of referrals in mental health service disparities for racial and ethnic minority youth. J Am Ac Child Adolesc Psychiatry 51(7):703–711.e2

    Article  Google Scholar 

  52. Verhulp EE, Stevens GW, van de Schoot R, Vollebergh WA (2013) Understanding ethnic differences in mental health service use for adolescents’ internalizing problems: the role of emotional problem identification. Eur Child Adolesc Psychiatry 22(7):413–421

    Article  PubMed  Google Scholar 

  53. Wittkampf L, Smeets H, Knol M, Geerlings M, Bram A, de Wit N (2010) Differences in psychotropic drug prescriptions among ethnic groups in the Netherlands. Soc Psychiat Epidemiol 45:819–826

    Article  Google Scholar 

  54. Lipkin PH, Cozen MA, Thompson RE, Mostofsky SH (2005) Stimulant dosage and age, race, and insurance type in a sample of children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15(2):240–248

    Article  PubMed  Google Scholar 

  55. Knol F (2012) Development status of Dutch neighborhoods 1998–2010. Sociaal Cultureel Planbureau (in Dutch)

  56. Tolan PH, Henry D (1996) Patterns of psychopathology among urban poor children: comorbidity and aggression effects. J Consult Clin Psychol 64(5):1094–1099

    Article  CAS  PubMed  Google Scholar 

  57. Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H et al (2013) Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. J Child Psychol Psychiatry 54(5):527–535

    Article  PubMed  Google Scholar 

  58. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J et al (2006) Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15(8):476–495

    Article  PubMed  Google Scholar 

  59. Brown R, Pacini J (1989) Perceived family functioning, marital status, and depression in parents of boys with attention deficit disorder. J Learn Disab 22(9):581–587

    Article  CAS  Google Scholar 

  60. Barkley R, Guevremont D, Anastopoulos A, DuPaul G, Shelton T (1993) Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey. Pediatrics 92(2):212–218

    CAS  PubMed  Google Scholar 

  61. Leibson CL, Katusic SK, Barbaresi WJ, Ransom J, O’Brien PC (2001) Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. J Am Med Assoc 285(1):60–66

    Article  CAS  Google Scholar 

  62. Swensen AR, Birnbaum HG, Secnik K, Marynchenko M, Greenberg P, Claxton A (2003) Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Ac Child Adolesc Psychiatry 42(12):1415–1423

    Article  Google Scholar 

  63. Swensen A, Birnbaum H, Hamadi R, Greenberg P, Cremieux P, Secnik K (2004) Incidence and costs of accidents among attention/deficit disorder patients. J Adolesc Health 35:346e1–346e9

    Article  Google Scholar 

  64. Hakkaart-van Roijen L, Zwirs B, Bouwmans C, Tan S, Schulpen T, Vlasveld L et al (2007) Social costs and quality of life of children suffering from attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry 16:316–326

    Article  CAS  PubMed  Google Scholar 

  65. Coghill D, Soutello C, d’ Aubuisson C, Preuss U, Lindback T, Silverberg M et al (2008) Impact of attention-deficit/hyperactivity disorder on the patient and family: results from a European survey. J Child Adolesc Psychiatry Ment Health 2(1):31

    Article  Google Scholar 

  66. Sobanski E, Brüggemann D, Alm B, Kern S, Philipsen A, Schmalzried H et al (2008) Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment. Eur Psychiatry 23:142–149

    Article  PubMed  Google Scholar 

  67. Bussing R, Mason D, Bell L, Porter P, Garvan C (2010) adolescent outcome of childhood attention-deficit/hyperactivity disorder in a diverse community sample. J Am Acad Cild Adolesc Psychiatry 49(6):595–605

    Google Scholar 

  68. Meyers J, Classi P, Wietecha L, Candrill S (2010) Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States. Child Adolesc Psychiatry Ment Health 14(4):31

    Article  Google Scholar 

  69. Charach A, Yeung E, Climans T, Lillie E (2011) Childhood attention deficit/hyperactivity disorder and the future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 50:9–21

    Article  PubMed  Google Scholar 

  70. Lee S, Humphreys K, Flory K, Liu R, Glass K (2011) Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 31:328–341

    Article  PubMed Central  PubMed  Google Scholar 

  71. Ginsberg Y, Långström N, Larsson H, Lichtenstein P (2013) ADHD and criminality: could treatment benefit prisoners with ADHD who are at higher risk of reoffending? Expert Rev Neurother 13(4):345–348

    Article  CAS  PubMed  Google Scholar 

  72. Lichtenstein P, Halldner L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S et al (2012) Medication for attention deficit-hyperactivity disorder and criminality. N Engl J Med 367(21):2006–2014

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Statistics Netherlands (CBS) (2010) StatLine database. http://www.cbs.nl/nl-NL/menu/themas/gezondheid-welzijn/publicaties/artikelen/archief/2010/2010-3087-wm.htm. Accessed 16 Oct 2014

  74. Statistics Netherlands (CBS) (2007) StatLine database. Bevolkingstrends, 4e kwartaal. http://www.cbs.nl. Accessed 16 Oct 2014

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Els F. van den Ban.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

van den Ban, E.F., Souverein, P.C., van Engeland, H. et al. Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands. Soc Psychiatry Psychiatr Epidemiol 50, 1153–1162 (2015). https://doi.org/10.1007/s00127-015-1068-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00127-015-1068-4

Keywords

Navigation